FDA staff raises no new concerns about Abbott's heart device

The U.S. Food and Drug Administration (FDA) staff reviewers did not raise any new concerns on Friday over the safety and effectiveness of Abbott's (ABT.N), opens new tab heart valve repair device designed for patients who are at risk for surgery.